{
    "title": "AstraZenenca assesses two drugs for use against effects of Covid-19",
    "url": "https://www.dailymail.co.uk/wires/pa/article-8268747/AstraZenenca-assesses-two-drugs-use-against-effects-Covid-19.html",
    "date": "2020-04-29",
    "keywords": [
        "covid19",
        "astrazeneca",
        "giant",
        "astrazenenca",
        "use",
        "failure",
        "pandemic",
        "wednesday",
        "quarter",
        "trading",
        "firm",
        "calquence",
        "drug",
        "leukaemia",
        "inflammation",
        "heart",
        "kidney",
        "disease",
        "research",
        "part",
        "accord",
        "uk",
        "aiming",
        "development",
        "httpstconsonpvehcg",
        "pictwittercomjdhyaan1k3",
        "chief",
        "executive",
        "soriot",
        "prouder",
        "team",
        "continuity",
        "care",
        "contribute",
        "society",
        "expertise",
        "damage",
        "cytokine",
        "storm",
        "hyperinflammatory",
        "state",
        "virus",
        "prove",
        "astrazenencapa",
        "jump",
        "response",
        "percentage",
        "benefit",
        "inventory",
        "effect",
        "today",
        "science",
        "fight",
        "httpstco5wvwlg7jk1",
        "azn",
        "pictwittercomu98knh1dmb",
        "year",
        "boost",
        "guidance",
        "company"
    ],
    "category": [
        "wires",
        "pa"
    ]
}